Hyundai Mobis Co Ltd (012330)
KOSDAQ · Korea · prices in KRW · close of 22 Oct 2026
Key indicators
| Last close | KRW 337,000.00 |
|---|---|
| 52-week range | 283,000.00 – 822,000.00 |
| Return, 1 month / 3 months | −9.5% / −34.1% |
| Return, 1 year / 3 years | +8.7% / +63.4% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 68.0% |
| Worst drawdown (1 year) | -56.0% |
| Average daily value traded | 128,225.63M KRW |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hyundai Mobis makes and supplies automotive parts and modules for vehicle manufacturers, chiefly within the Hyundai Motor Group. Its products include cockpit modules, chassis modules, front-end modules and a wide range of aftermarket service parts, along with electronics and safety components. The company is based in Seoul, South Korea, and serves carmakers and repair markets in Korea and overseas.
The shares are listed on the KOSDAQ in Korea under the code 012330, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hyundai Mobis Co Ltd (012330) trades on the KOSDAQ in Korea. It last closed at KRW 337,000.00 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 678 of 1,832 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.7% and over the last three months it fell 34.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -26.9% | ||
| From 52-week high | -56.1% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -34.1% | ||
| 6-month return | -26.0% | ||
| 12-month return, skipping the last month | 20.2% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 68.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -56.0% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 128,225.63M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | −9.5% |
| 3 months | −34.1% |
| 6 months | −26.0% |
| 1 year | +8.7% |
| 3 years | +63.4% |
| 5 years | +39.5% |
Signals
| 50-day / 200-day average | 417,660.00 / 461,238.44 |
|---|---|
| Golden / death cross (60 days) | Death, 17 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17,487.09 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Aug 2026 | KRW 1,500.0000 |
| 19 Mar 2026 | KRW 5,000.0000 |
| 8 Aug 2025 | KRW 1,500.0000 |
| 21 Mar 2025 | KRW 5,000.0000 |
| 27 Jun 2024 | KRW 1,000.0000 |
| 22 Mar 2024 | KRW 3,500.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.